Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
BMC Bioinformatics ; 13 Suppl 1: S10, 2012 01 25.
Artículo en Inglés | MEDLINE | ID: mdl-22373303

RESUMEN

BACKGROUND: The RDF triple provides a simple linguistic means of describing limitless types of information. Triples can be flexibly combined into a unified data source we call a semantic model. Semantic models open new possibilities for the integration of variegated biological data. We use Semantic Web technology to explicate high throughput clinical data in the context of fundamental biological knowledge. We have extended Corvus, a data warehouse which provides a uniform interface to various forms of Omics data, by providing a SPARQL endpoint. With the querying and reasoning tools made possible by the Semantic Web, we were able to explore quantitative semantic models retrieved from Corvus in the light of systematic biological knowledge. RESULTS: For this paper, we merged semantic models containing genomic, transcriptomic and epigenomic data from melanoma samples with two semantic models of functional data - one containing Gene Ontology (GO) data, the other, regulatory networks constructed from transcription factor binding information. These two semantic models were created in an ad hoc manner but support a common interface for integration with the quantitative semantic models. Such combined semantic models allow us to pose significant translational medicine questions. Here, we study the interplay between a cell's molecular state and its response to anti-cancer therapy by exploring the resistance of cancer cells to Decitabine, a demethylating agent. CONCLUSIONS: We were able to generate a testable hypothesis to explain how Decitabine fights cancer - namely, that it targets apoptosis-related gene promoters predominantly in Decitabine-sensitive cell lines, thus conveying its cytotoxic effect by activating the apoptosis pathway. Our research provides a framework whereby similar hypotheses can be developed easily.


Asunto(s)
Epigenómica , Perfilación de la Expresión Génica , Internet , Melanoma/genética , Semántica , Azacitidina/análogos & derivados , Azacitidina/farmacología , Sistemas de Administración de Bases de Datos , Decitabina , Resistencia a Antineoplásicos/genética , Ontología de Genes , Redes Reguladoras de Genes , Humanos , Melanoma/tratamiento farmacológico , Melanoma/patología , Factores de Transcripción/metabolismo , Investigación Biomédica Traslacional
2.
Sci Data ; 9(1): 239, 2022 05 27.
Artículo en Inglés | MEDLINE | ID: mdl-35624233

RESUMEN

Graph databases capture richly linked domain knowledge by integrating heterogeneous data and metadata into a unified representation. Here, we present the use of bespoke, interactive data graphics (bar charts, scatter plots, etc.) for visual exploration of a knowledge graph. By modeling a chart as a set of metadata that describes semantic context (SPARQL query) separately from visual context (Vega-Lite specification), we leverage the high-level, declarative nature of the SPARQL and Vega-Lite grammars to concisely specify web-based, interactive data graphics synchronized to a knowledge graph. Resources with dereferenceable URIs (uniform resource identifiers) can employ the hyperlink encoding channel or image marks in Vega-Lite to amplify the information content of a given data graphic, and published charts populate a browsable gallery of the database. We discuss design considerations that arise in relation to portability, persistence, and performance. Altogether, this pairing of SPARQL and Vega-Lite-demonstrated here in the domain of polymer nanocomposite materials science-offers an extensible approach to FAIR (findable, accessible, interoperable, reusable) scientific data visualization within a knowledge graph framework.

3.
BMC Bioinformatics ; 10 Suppl 10: S2, 2009 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-19796399

RESUMEN

The National Cancer Institute (NCI) is developing caGrid as a means for sharing cancer-related data and services. As more data sets become available on caGrid, we need effective ways of accessing and integrating this information. Although the data models exposed on caGrid are semantically well annotated, it is currently up to the caGrid client to infer relationships between the different models and their classes. In this paper, we present a Semantic Web-based data warehouse (Corvus) for creating relationships among caGrid models. This is accomplished through the transformation of semantically-annotated caBIG Unified Modeling Language (UML) information models into Web Ontology Language (OWL) ontologies that preserve those semantics. We demonstrate the validity of the approach by Semantic Extraction, Transformation and Loading (SETL) of data from two caGrid data sources, caTissue and caArray, as well as alignment and query of those sources in Corvus. We argue that semantic integration is necessary for integration of data from distributed web services and that Corvus is a useful way of accomplishing this. Our approach is generalizable and of broad utility to researchers facing similar integration challenges.


Asunto(s)
Biología Computacional/métodos , Almacenamiento y Recuperación de la Información/métodos , Internet , Neoplasias/metabolismo , Biomarcadores de Tumor/química , Bases de Datos de Proteínas , Humanos , Proteínas de Neoplasias/química , Semántica , Interfaz Usuario-Computador
4.
Nat Genet ; 47(9): 996-1002, 2015 09.
Artículo en Inglés | MEDLINE | ID: mdl-26214590

RESUMEN

We report on whole-exome sequencing (WES) of 213 melanomas. Our analysis established NF1, encoding a negative regulator of RAS, as the third most frequently mutated gene in melanoma, after BRAF and NRAS. Inactivating NF1 mutations were present in 46% of melanomas expressing wild-type BRAF and RAS, occurred in older patients and showed a distinct pattern of co-mutation with other RASopathy genes, particularly RASA2. Functional studies showed that NF1 suppression led to increased RAS activation in most, but not all, melanoma cases. In addition, loss of NF1 did not predict sensitivity to MEK or ERK inhibitors. The rebound pathway, as seen by the induction of phosphorylated MEK, occurred in cells both sensitive and resistant to the studied drugs. We conclude that NF1 is a key tumor suppressor lost in melanomas, and that concurrent RASopathy gene mutations may enhance its role in melanomagenesis.


Asunto(s)
Exoma , Melanoma/genética , Neurofibromina 1/genética , Neoplasias Cutáneas/genética , Antineoplásicos/farmacología , Bencimidazoles/farmacología , Análisis Mutacional de ADN , Resistencia a Antineoplásicos , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Humanos , Concentración 50 Inhibidora , Estimación de Kaplan-Meier , Pérdida de Heterocigocidad , Masculino , Melanoma/tratamiento farmacológico , Melanoma/etiología , Mutación Missense , Análisis de Secuencia de ARN , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/etiología , Luz Solar/efectos adversos , Células Tumorales Cultivadas , Proteínas ras/genética
5.
J Biomed Semantics ; 5(1): 14, 2014 03 06.
Artículo en Inglés | MEDLINE | ID: mdl-24602174

RESUMEN

The Semanticscience Integrated Ontology (SIO) is an ontology to facilitate biomedical knowledge discovery. SIO features a simple upper level comprised of essential types and relations for the rich description of arbitrary (real, hypothesized, virtual, fictional) objects, processes and their attributes. SIO specifies simple design patterns to describe and associate qualities, capabilities, functions, quantities, and informational entities including textual, geometrical, and mathematical entities, and provides specific extensions in the domains of chemistry, biology, biochemistry, and bioinformatics. SIO provides an ontological foundation for the Bio2RDF linked data for the life sciences project and is used for semantic integration and discovery for SADI-based semantic web services. SIO is freely available to all users under a creative commons by attribution license. See website for further information: http://sio.semanticscience.org.

6.
J Biomed Semantics ; 2 Suppl 2: S1, 2011 05 17.
Artículo en Inglés | MEDLINE | ID: mdl-21624155

RESUMEN

BACKGROUND: Translational medicine requires the integration of knowledge using heterogeneous data from health care to the life sciences. Here, we describe a collaborative effort to produce a prototype Translational Medicine Knowledge Base (TMKB) capable of answering questions relating to clinical practice and pharmaceutical drug discovery. RESULTS: We developed the Translational Medicine Ontology (TMO) as a unifying ontology to integrate chemical, genomic and proteomic data with disease, treatment, and electronic health records. We demonstrate the use of Semantic Web technologies in the integration of patient and biomedical data, and reveal how such a knowledge base can aid physicians in providing tailored patient care and facilitate the recruitment of patients into active clinical trials. Thus, patients, physicians and researchers may explore the knowledge base to better understand therapeutic options, efficacy, and mechanisms of action. CONCLUSIONS: This work takes an important step in using Semantic Web technologies to facilitate integration of relevant, distributed, external sources and progress towards a computational platform to support personalized medicine. AVAILABILITY: TMO can be downloaded from http://code.google.com/p/translationalmedicineontology and TMKB can be accessed at http://tm.semanticscience.org/sparql.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA